SONG Hui Outline Anticoagulants ( 抗凝 ) Anticoagulants ( 抗凝 ) Thrombolytic agents ( 纤溶 ) Thrombolytic agents ( 纤溶 ) Coagulants ( 促凝 ) Coagulants ( 促凝.

Slides:



Advertisements
Similar presentations
Chapter 19 Hematologic Products.
Advertisements

Chapter 12 Disorders of Hemostasis
Hemostasis, Surgical Bleeding, and Transfusion
Haemostasis Prof. K. Sivapalan.
Chapter 36 Drugs acting on the blood and blood-forming organs.
Drugs for Coagulation Disorders Andrew N. Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University October 8, 2008
Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Blood.
Blood Week 7 Dr. Walid Daoud A. Professor. Anemia ____________________________ Anemia is decrease in O2 carrying capacity of blood due to: 1- Decreased.
Basic Principles of Hemostasis
Cardiovascular System: Blood
HEMOSTAZ Yard. Doç. Dr. Murat ÖRMEN. Vessels Platelets Fibrinolysis/Inhibitors Coagulation Proteins BleedingClotting Hemostaz.
Vascular Pharmacology
Blood S-J Tsai Department of Physiology. Composition Composed of cells (erythrocytes, leukocytes, and platelets) and plasma (the liquid in which the cells.
Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.
Blood coagulation and fibrinolysis Professor Asim K. Duttaroy University of Oslo.
Hemostasis and Blood Coagulation
Implant of a Medical Device and the Wound Healing Process.
Anticoagulant, Fibrinolytic and Antiplatelet
Drug Affecting hematopoiesis system
NURS 1950 Pharmacology I 1.  Objective 1: identify general reasons anticoagulants are given 2.
Drugs used in coagulation disorders By S.Bohlooli, Ph.D.
Anticoagulant, Antiplatelet, and Thrombolytic Drugs
COAGULATION & ANTICOAGULATION Dr Rakesh Jain. A set of reactions in which blood is transformed from a liquid to a gel Coagulation follows intrinsic and.
Antiplatelet Drugs - Principles Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Drugs affecting haemostasis, Antianemic drugs A. Kohút.
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
Anticoagulants 1. Parenteral Anticoagulants e.g. heparin
Coagulation Mechanisms
 Stored in the body as ferritin  Deficiency result from negative iron balance due to depletion of stores and/or inadequate intake.  Iron deficiency.
Developed by: Dawn Johnson, RN, MSN, Ed.  Internally and externally  Prevent bleeding from wounds which could lead to shock or even death.
ASPIRIN ↓ Cox inhibition ↓ (PROSTACYCLIN) PGI 2 & TXA 2 (THROMBOXANE) LOW DOSE ASPIRIN.
DISORDERS OF HEMOSTASIS Dept.of Hematology ZhongShan Hospital,FuDan University Prof. JlAN-MIN XU.
Fibrinolytics, anticoagulants and antiplatelets
Objectives At the end of this lecture student should be able to: 1.Recognize different stages of hemostasis 2.Describe formation and development.
PLATELETS (PLTs) or Thrombocytes Dr. Taj Platelets Thrombocytes are Fragments of megakaryocytes in bone marrow.
Drugs acting on the blood and blood-forming organs Yun-Bi Lu, PhD 卢韵碧 Dept. of Pharmacology, School of Medicine, Zhejiang University
Anticoagulants, Thrombolytic Agents and Antiplatelet Drugs
Agents Affecting Blood Clotting
Chapter 22 Agents Used to Treat Anemias. Anemia p526 Decrease in hemoglobin or decrease in RBCs Many causes of anemia – Iron deficiency anemia – Chemotherapy.
DRUGS FOR BLOOD COAGULATION DISORDERS This study material is recommended specifically for practical courses from Pharmacology II for students of general.
Dr. Laila M. Matalqah Ph.D. Pharmacology
Coagulation Modifier Agents Lilley Pharmacology Text: Chapter 26 Original Text modified by: Anita A. Kovalsky, R.N., M.N.Ed. Professor of Nursing Original.
Coagulation and fibrinolysis
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
بسم الله الرحمن الرحيم.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Drugs Used in Coagulation Disorders
II. Antiplatelet Drugs.
23 Anticoagulants.
Factors against intravascular clotting]
These factors prevent blood clotting - in normal state.
General Principles of Hemostasis Kristine Krafts, M.D.
Drugs Used in Coagulation Disorders
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
and anti-thrombotic pharmocology Tom Williams
Coagulation Disorders
Implant of a Medical Device and the Wound Healing Process.
General Principles of Hemostasis Kristine Krafts, M.D.
23 Anticoagulants.
Drugs Affecting Blood.
Drugs affecting blood and blood-forming organs
Anticoagulants.
Antiplatelet Drugs Dr. : Asmaa Fady MD., MSC, M.B, B.Ch
Section B: Science update
Presentation transcript:

SONG Hui

Outline Anticoagulants ( 抗凝 ) Anticoagulants ( 抗凝 ) Thrombolytic agents ( 纤溶 ) Thrombolytic agents ( 纤溶 ) Coagulants ( 促凝 ) Coagulants ( 促凝 ) Anti- Anemia ( 扶贫 ) Anti- Anemia ( 扶贫 ) White cells stimulants ( 增白 ) White cells stimulants ( 增白 ) Blood volume increasing Agents ( 扩容 ) Blood volume increasing Agents ( 扩容 )

Anticoagulants Thrombolytic agents Coagulants

Background Hemostasis Process Vessel contraction Vessel contraction Thrombokinesis Thrombokinesis Platelets aggregation Fibrin formation Fibrinolysis Fibrinolysis

Background Fa II II a Fg Fb PgPlasmin Pg Plasmin Activators + PAI

Anticoagulants

Classification Anti-factors: Anti-factors: Heparin, Warfarin Anti-platelet agents: Anti-platelet agents: Aspirin, Persantin,Ticlid Thrombolytic agents Thrombolytic agents SK, UK, t-PA

Anti-factors Heparin Heparin II a structure structure IX a MOA AT III X a(LMWH) MOA AT III X a(LMWH) XI a XI a Heparin XII a Heparin XII a

Heparin Uses: prevention of thrombi (DIC,MI) Dose control: PT, <10d ADR: Bleed Protamine hypersensitivity, osteoporosis Notice: HBP, ulcer, pregnancy

Warfarin P.O only, in vivo, effect: 24hr later MOA antagonist of V.K IIVII IX IXXPCPS II a VIIa IX a X a PCaPSa KH 2 KO Carboxylase r- 羧化酶 Warfarin

Warfarin Uses Uses Prevention of Thrombi in venous Prevention of Thrombi in venous interaction interaction Dose control PT Dose control PT ADR: bleeding, necrosis ADR: bleeding, necrosis

Anti-platelet agents Platelets aggregation MOA Platelets aggregation Agents: Agents: — COX TXA2, ADP Aspirin — COX TXA2, ADP Aspirin — PDE Camp Ca Persantin — PDE Camp Ca Persantin — PLT aggregation factors Ticlid — PLT aggregation factors Ticlid — Gp IIb/IIIa Tirofiban — Gp IIb/IIIa Tirofiban CVS Uses: to prevent thrombin formation in CVS

Thrombolytic agents

MOA plasminogen MOA plasminogen activate SK, UK, t-PA activate SK, UK, t-PA plasmin plasmin fibrinogen,fibrin fibrinogen, fibrin Uses 2-8 hs after MI

Coagulants

Classification Adrenosem,pituitrin vessel contractor (Adrenosem,pituitrin) platelet K 1,2 - nature, fat-soluble Vitamin K (K 1,2 - nature, fat-soluble K 3,4 - synthetic, WS K 3,4 - synthetic, WS ) Reptilase thrombin (Reptilase) PAMBA, AMCHA fibrinogen / fibrin (PAMBA, AMCHA)

Songhui

Outline Anti-Anemia agents White cells stimulants White cells stimulants Blood Volume Increasing agents

Anti-Anemia

Iron-deficiency anemia Iron-deficiency anemia Megaloblastic anemia Megaloblastic anemia Classification

Iron-deficiency anemia Backgroud Backgroud Hb Iron: Hb red meat supply: red meat absorption & storage: Fe Vit.C HCl Fe ++ Fe +++ t&s Fe ++ Fe Vit.C HCl Fe ++ Fe +++ t&s Fe ++ diagnosis: PT/TIBC < 10%(35%) Symptoms: fatigue, pica

Iron-deficiency anemia Agents Agents Oral ferrous sulfate Parenteral iron dextran ADR ADR stimulating reactions Overdose----phosphate deferoxamine

Megaloblastic anemia Backgroud: folic acid, VB 12 folic acid, VB 12 Supply: Vegetable, Animal Supply: Vegetable, Animal Function: DNA, lipin Function: DNA, lipin

Megaloblastic anemia L-MCoA ScCoA LIPIN FH2 E Folate E 5-MFH 4 CH3 B12 B12 E FH4 C-FH4 CH3-B12 dUMP dTMP DNA C Homocysteine Methionine A: B12 B: 半胱氨酸 蛋氨酸 甲基丙二酰 CoA 琥珀酰 CoA B12 B12 E 尿嘧啶脱氧核苷酸 胸腺嘧啶脱氧核苷酸

Megaloblastic anemia Folic acid RNA: DNA Megaloblastic anemia absorbed in intestine: 5-MFH 4 5-MFH 4 liver Therapy B 12 folic acid(calcium leucovorin)+ B 12

Megaloblastic anemia B 12 B 12 Background mainly from animal absorbed with IF Storage in liver 5-MFH4 B12 FH4 lipin synthesis of nerves

Megaloblastic anemia Deficiency FH4 Megaloblastic anemia & CNS symptoms Etiology Some gastrointestinal diseases IF therapy B 12 & folic acid use together. B 12 & folic acid use together.

Depression of the bone marrow Depression of the bone marrow Anemia associated with chronic renal failure (CRF) Anemia associated with chronic renal failure (CRF)

Anemia from CRF Erythropoietin (EPO) Effect: RBC Uses: CRF, Iron deficiency, Marrow injury, tumors, AIDS. Agent: ESPO

WBC stimulants---CSF G-CSF: PMN GM-CSF: PMN,MO,Macrophage,PLT USEs Marrow inhibited situations, Chemistry or Radiopraxis Marrow inhibited situations, Chemistry or Radiopraxis AIDS AIDS anemia anemia

B.V. increasing Agents (Dextran): Features (Dextran): Colloid Osmotic Pressure of plasma excretion is slow no toxicity no antigenicity

Questions

Where are the action sites of Anticoagulants and Thrombolytic agents respectively ? Which kind of drug would you choose for an AMI (<8hr.s) patient? A. Antiplatelets B. Coagulants C. Thrombolytics D. Anticoagulants

Questions Which factors formation dependend on V-K? And which can be inactivated by heparin? A. I A’. Ia B. II B’. IIa C. VII C’. XIa D. IX D’. IXa E. X E’. Xa F. XII F’. XIIa

Questions 1.What is the active form of folic acid? 2. The functions of B Why some patients will get anemia after stomach excision?

Questions Which would u choose for the patients with Megaloblastic anemia? Iron agents Iron agents Folic acid only Folic acid only G-CFS G-CFS Folic acid & B12 Folic acid & B12